Regulated information

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2018

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Strong growth in all key financial indicators in 2017 ebit up 9.4% to €46.0 million net income - group share up 25.2% to €34.8 million

At its meeting on March 14, 2018, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited 2017 financial statements. 

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2018

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2018

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

2017 sales: €352.2 million 7.6% like-for-like growth in essentials products

The Vetoquinol Group posted sales of €352.2 million for the 2017 financial year, up 1.0% like-forlike. After a negative currency impact of 0.5%, mainly linked to the US and Canadian dollars, reported growth amounted to 0.5%.  

Monthly information regarding the total number of voting rights and shares making of the share capital - December 2017

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

Vetoquinol et nippon Zenyaku Kogyo Co. ltd. signent un accord de joint-venture au Japon

Vetoquinol and Nippon Zenyaku Kogyo Co., Ltd., also operating under the trade name “Zenoaq”, announced today the signature of a joint-venture agreement to develop, register and market a range of animal health products in Japan.

Monthly information regarding the total number of voting rights and shares making of the share capital - Octobre 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

September 2015 year-to-date sales up 8.7% to €251.8 million

Vetoquinol sales for the first nine months of 2015 rose 8.7% to €251.8 million, boosted by a positive currency impact of €13.7 million. Organic growth for the same period came to 0.7%.